Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK5 | Q00535 | 7/20 | 0.53 |
| ▸ | CDK5R1 | Q15078 | 7/20 | 0.53 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.41 |
| ▸ | CDK2 | P24941 | 2/20 | 0.41 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.41 |
| ▸ | ROCK1 | Q13464 | 3/20 | 0.40 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.38 |
| ▸ | GPR142 | Q7Z601 | 1/20 | 0.37 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | WNT3A | P56704 | 1/20 | 0.34 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5343143 | 0.89 | CDK5 (0.56) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL5348040 | 0.85 | CDK5 (0.53) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL7059666 | 0.83 | CDK5 (0.53) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL5345256 | 0.83 | CDK5 (0.61) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL14558460 | 0.80 | CDK5 (0.48) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL5338197 | 0.77 | CDK5 (0.65) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL5341105 | 0.75 | CDK5 (0.81) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL14558320 | 0.74 | CDK5 (0.67) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL14558339 | 0.72 | CDK5 (0.63) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL5345427 | 0.72 | CDK5 (0.54) | CDK5CDK5R1CCNA2CDK2CCNA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1309589-A2 | UREA COMPOUNDS AND METHODS OF USES | Amgen Inc. (US) | 2003-05-14 | — | — | EP | disclosed |
| WO-2002014311-A2 | UREA COMPOUNDS AND METHODS OF USES | AMGEN INC. (US) | 2002-02-21 | — | — | WO | disclosed |